Acellular Dermal Matrix Skin Substitutes


Chart_Collage_160    Published September 2015  •  Catalog no. ADM515F  •  Price US $2,850



Damage to skin tissue from refractory wounds, surgical procedures and injury represents a growing healthcare need. Shifting demographics will drive industry growth in the years ahead as an aging population provides further stimulus for tissue repair demand. Tissue engineering is now an emerging industry with research and development taking place in the world’s leading universities and companies worldwide. Emerging products and processes for wound management and tissue repair include a number of synthetic and bioengineered products that have recently become available, or are being developed, as adjuncts to wound care and/or as a replacement for human skin. Through their ability to address a number of clinical demands, acellular dermal matrices are positioned to benefit as the global market matures.

Bar_Graph  Acellular Dermal Matrix Skin Substitutes to 2020 Report Prospectus (Download PDF)

Blue document  Acellular Dermal Matrix Skin Substitutes to 2020 Report Order Form (Download PDF)


Highlights

• What are the key segments and patient demographics that comprise the market for engineered wound care?
• What are the major therapeutic demand drivers for acellular dermal matrices?
• What are the design factors, material selection issues and technologies that are being used in commercial and development-stage dermal matrix products?
• What is the market share and product position in the market and what will it look like in 2020?
• Who are the companies behind the current generation of engineered wound care products and what are their business models?
• What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging engineered wound therapies?
• What is the impact of economic, technology, and regulatory factors?


Summary of Contents

Executive Summary

The Global Market for Engineered Skin Substitutes

Therapeutic Markets
Disease Morbidity
Traumatic Dermal Insult
Surgical
Destructive
Dermal Matrix Product Categories
Autotografts
Allografts
Xenografts
Synthetic Substrates
Industry Profile
Industry Structure
Competitive Landscape
Enabling Technologies
Market Drivers

Dermal Matrix Product Technology Factors

Processing Technology
Storage
Shelf Life
Sterilization
Tissue Stability/Source Reliability

Dermal Matrix Product Supply Chains and Ecosystems

Sourcing
Proprietary Processing
Marketing/Distribution

Dermal Matrix Market Segment Analysis

Acute Trauma
Burns
Chronic Wounds
Diabetic Ulcers
Pressure Ulcers
Venous Ulcers

Dermal Matrix Product Analysis, Market Data & Forecasts

Autografts
Allografts
Xenografts
Bovine
Porcine
Other Xenograft Products

Market Factors

Regulatory Factors
Industry Initiatives
Alliances and Partnerships
Regional Market Factors
Managed Care and Reimbursement

Company Profiles